Peter D Gorevic, MD et al. Overview of amyloidosis. Literature review current through: May 2022. | This topic last updated: May 28, 2022. accessed in May 2022
Benson MD, Buxbaum JN, Eisenberg DS, Merlini G, Saraiva MJM, Sekijima Y, et al. Amyloid nomenclature 2018: recommendations by the International Society of Amyloidosis (ISA) nomenclature committee. Amyloid. 2018;25(4):215-9.
Seward B Rutkove, MD et al. Overview of polineuropathy. Literature review current through: May 2022. | This topic last updated: Dec 14, 2020. accessed in May 2022
https://myloview.com.br/quadro-human-nervous-system-no-C805728
https://www.utahfootdoc.com/library/peripheral-nerve-fiber-types.cfm
Matloub HS, Yousif NJ. Peripheral nerve anatomy and innervation pattern. Hand Clin. 1992 May;8(2):201-14. PMID: 1613029.
PINTO, Marcus Vinicius et al. Brazilian consensus for diagnosis, management and treatment of transthyretin familial amyloid polyneuropathy. Arquivos de Neuro-Psiquiatria [online], v. 76, n. 9, pp. 609-621, 2018. Disponível em: <https://doi.org/10.1590/0004-282X20180094>. Acesso em: 11 maio 2022
https://www.amyloidosissupport.org/AmyloidAware_Portuguese.pdf
Peter D Gorevic, MD et al. Overview of amyloidosis. Literature review current through: May 2022. | This topic last updated: May 28, 2022. accessed in May 2022
Luiz F. Pinto, MD and Marcus V. Pinto, MD, MS. Neuromuscular Amyloidosis The most common amyloidosis are both treatable; accurate diagnosis is paramount. PRACTICAL NEUROLOGY JULY/AUGUST 2021
Repezzi C et al.Disease profile and differential diagnosis of hereditary transthyretin-related amyloidosis with exclusively cardiac phenotype: na Italian perspective. Eur Heart. J. 2013 Feb;34(7):520-8
23 abr. 2024 
1 min. 
